Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Cosmed Pharmaceutical Co. Ltd. is managing 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 3 actions are handled by 2 distinct examiners, indicating some concentration of the workload. The prosecution is also limited to 2 distinct art units, suggesting a focused technical range for the company's pharmaceutical filings. WERTZ, ASHLEE ELIZABETH is the busiest examiner for the portfolio, currently responsible for 2 pending office actions.
For a practitioner, this concentration is significant, as the outcome of 2 out of the 3 pending office actions depends on a single examiner's perspective. The use of only 2 distinct art units for the 3 pending office actions further reinforces this focused approach. Practitioners should prioritize understanding the specific examination style of WERTZ, ASHLEE ELIZABETH, as their decisions will have a disproportionate impact on the overall success of the portfolio. This distribution requires a strategy that balances the needs of the majority workload under one examiner with the unique requirements of the remaining pending office action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WERTZ, ASHLEE ELIZABETH | 2 | 52.7% | +35.6% |
| KIM, SUN U | 1 | 78.2% | +11.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684654 | HIGH-PERFORMANCE MICRONEEDLE ARRAY | KIM, SUN U | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18565031 | SKIN CARE COMPOSITION FOR APPLICATION TO SKIN | WERTZ, ASHLEE ELIZABETH | 70d |
| 18849858 | SKIN EXTERNAL AGENT COMPOSITION IN WHICH FINE NEEDLE-LIKE OR COLUMNAR CRYSTALS OF TAURINE ARE BLENDED | WERTZ, ASHLEE ELIZABETH | — |
| 18684654 | HIGH-PERFORMANCE MICRONEEDLE ARRAY | KIM, SUN U | — |
| Art Unit | Apps |
|---|---|
| 1612 | 2 |
| 1772 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18849858 | SKIN EXTERNAL AGENT COMPOSITION IN WHICH FINE NEEDLE-LIKE OR COLUMNAR CRYSTALS OF TAURINE ARE BLENDED | WERTZ, ASHLEE ELIZABETH | 1612 | §102§103§112DP | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18684654 | HIGH-PERFORMANCE MICRONEEDLE ARRAY | KIM, SUN U | 1772 | §102§103 | Final Rejection | — | Pending | Feb 16, 2024 |
| 18565031 | SKIN CARE COMPOSITION FOR APPLICATION TO SKIN | WERTZ, ASHLEE ELIZABETH | 1612 | §103DP | Final Rejection | 70d | Pending | Nov 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCosmed Pharmaceutical Co. Ltd. has 3 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Ashlee Elizabeth Wertz has the most, with 2 of Cosmed Pharmaceutical Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
